Clinical Trial Update: Study to Assess the Efficacy and Safety of Budesonide (PT008) in Adult Subjects With Mild to Moderate Persistent Asthma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of Budesonide PT008 in adults with mild-to-moderate persistent asthma completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Budesonide (PT008) (budesonide)

Snippet

Sponsor: Pearl Therapeutics, Inc. | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2017-06-06